DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Varian acquires Noona Healthcare Gains mobile service app that captures PROs

Philly leads US cities in need of radiologists Shortages continue to leave radiologists in high demand

Siemens Healthineers holds grand opening of new Erlangen HQ Continuing its 140 year presence in the city

Does GE CEO move cast doubt on healthcare spinoff? Industry analysts weigh in on how this could change the game plan

Healthcare has a serious problem with wasted spending How supply chain can hold the key to more efficient hospital finances

Mass imaging exam cancellations by VA puts veterans lives at risk Medically needed scans reportedly removed from schedule to reduce backlog

Hologic to acquire Focal Therapeutics for $125 million Furthering its expansion into the breast conservation surgery market

GE CEO Flannery is out as Culp Jr. named chairman and CEO The latest shake-up in a year full of transitions

China tariffs now hit $4.7 billion worth of U.S. medical devices AdvaMed warns that things could get worse before they get better

Philips inks 15-year $75 million MES deal with Children’s Health in Texas Are these contracts the future of value-based care?

Johnson & Johnson acquires Emerging Implant Technologies GmbH

by Thomas Dworetzky , Contributing Reporter
Johnson & Johnson Medical GmbH, a subsidiary of Johnson & Johnson Medical Devices Companies, has announced that it is acquiring privately-held Emerging Implant Technologies GmbH (EIT).

"Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients," said Aldo Denti, Company Group Chairman of DePuy Synthes. "We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes."

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



EIT, based in Wurmlingen, Germany, makes 3D-printed titanium interbody implants for spinal fusion surgery. These implants use a proprietary cellular titanium made of an open and interconnected porous structure that lets bone securely grow into the implant.

This deal will add to the interbody portfolio of products from DePuy Synthes, the orthopedics business of J&J, which includes expandable interbody devices, titanium-integrated PEEK technology and now 3D-printed cellular titanium, for both minimally-invasive and open spinal surgery.

The new technology fits in with other DePuy Synthes investments including recently introduced Concorde Lift expandable interbody device, and in the U.S., the PROTI 360° family of titanium-integrated interbody implants, which are used for degenerative disc disease.

Plans are for DePuy Synthes to maintain its focus on spinal disease best helped by surgery, including degenerative disc disease, deformity and complex cervical issues.

No financial details were disclosed.

In February, J&J made a move to bulk up its position in the robotic-assisted surgical market when it acquired Orthotaxy, a developer of software-enabled surgery technology, as part of a plan to develop a platform for a variety of care settings in orthopedics.

The purchase provides Johnson & Johnson access to Orthotaxy’s robotic-assisted surgery solution, a proprietary technology in early stage development for total and partial knee replacement, with the former intending to broaden its application for a range of orthopedic procedures and market it as a cost-effective, time-efficient and user-friendly product.

“Health care providers and surgeons are shifting from volume to value-based care and need technologies and solutions that help reduce costs, improve outcomes and enhance patient satisfaction,” Ciro Romer, company group chair of Johnson & Johnson’s orthopedic's business, DePuy Synthes, told HCB News. “In order for robotic-assisted surgery to continue to play a long-term role in this new environment, the technology must evolve from being a costly surgical add-on into part of a holistic platform that supports customers and patients throughout the episode of care.”

Back to HCB News
  Pages: 1

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED